Pfizer Inc.

NYSE:PFE

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💉 Vaccines

Location

United States

Market Cap

USD 139.75 B

Share Price

USD 24.58

Avg Daily Volume

42,506,228

Change (1 day)

1.44%

Change (1 year)

-14.53%

Change (YTD)

-7.35%

Pfizer Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 29, 2025: 25.04%

Pfizer Inc. EBIT Margin is 25.04% for the Trailing 12 Months (TTM) ending June 29, 2025, a -1,262.69% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Pfizer Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -2.15%, a -106.97% change year over year.
Pfizer Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 02, 2023 was 30.89%, a -6.39% change year over year.
Pfizer Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 03, 2022 was 33.00%, a 20.86% change year over year.
Pfizer Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 04, 2021 was 27.30%, a -25.77% change year over year.